OPKO Health, Inc. (OPK) Stock Forecast
OPK analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 6 analysts
- Price target
- $4.15 average of analyst targets
- Upside to target
- +171.2% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $-0.07
- 52-week range
- $1.10 – $1.73
OPK analyst ratings
6 analystsNumber of analysts at each rating.
OPK price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
OPK earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.06 | −$0.08 | −$0.05 | — | — | 3 |
| Current fiscal year (2026) | −$0.21 | −$0.22 | −$0.20 | −$0.30 | +16.7% | 2 |
| Next fiscal year (2027) | −$0.34 | −$0.48 | −$0.26 | −$0.21 | −63.5% | 3 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
OPK revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $136.6M | $135.0M | $138.0M | −9.9% | 6 |
| Current fiscal year (2026) | $569.9M | $566.4M | $572.8M | −6.1% | 6 |
| Next fiscal year (2027) | $495.1M | $307.4M | $596.0M | −13.1% | 6 |
OPK EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
OPK revenue: reported and forecast
OPK EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.11 | −$0.07 | −$0.07 | −$0.06 | −$0.06 | −42.5% | 1 up · 0 down |
| Current fiscal year (2026) | −$0.38 | −$0.22 | −$0.22 | −$0.21 | −$0.21 | −44.7% | 1 up · 0 down |
| Next fiscal year (2027) | −$0.32 | −$0.28 | −$0.28 | −$0.27 | −$0.34 | +7.3% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
OPK earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; OPK beat in 10 of 12.
What analysts expect from OPK
6 analysts cover OPKO Health; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $4.15, 171.2% above the latest close of $1.53. Analysts expect earnings of −$0.21 per share for 2026, +16.7% from a year earlier. For 2027 the average estimate is −$0.34 per share on revenue of $495.1 million. OPKO Health beat the EPS estimate in 10 of the last 12 quarters.
Related: OPK income statement, OPK key metrics, OPK chart. See the OPK stock overview for the latest quote and news.
OPK forecast FAQ
What is OPKO Health's price target?
The average analyst price target for OPKO Health is $4.15, 171.2% above the latest close of $1.53.
Is OPKO Health a buy, hold or sell?
Of 6 analysts covering OPKO Health, 2 rate it a strong buy, 2 a buy, 2 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is OPKO Health's EPS forecast?
Analysts forecast −$0.21 per share for 2026 (range −$0.22 to −$0.20); for 2027 the estimate is −$0.34.
What is OPKO Health's revenue forecast?
The average revenue estimate for 2026 is $569.9 million, growth of −6.1%; for 2027 it is $495.1 million.
When does OPKO Health report earnings?
OPKO Health is expected to report results for the quarter ending September 30, 2026 on November 4, 2026; the EPS estimate is $-0.07.
Does OPKO Health usually beat earnings estimates?
OPKO Health reported EPS at or above the analyst estimate in 10 of the last 12 quarters.